Literature DB >> 32944357

The public health response to the COVID-19 outbreak in mainland China: a narrative review.

Mark Zanin1,2,3, Cheng Xiao1, Tingting Liang1, Shiman Ling1, Fengming Zhao1, Zhenting Huang1, Fangmei Lin1, Xia Lin1, Zhanpeng Jiang1, Sook-San Wong1,2,3.   

Abstract

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused nations to adopt unprecedented control measures in order to curb its spread. As the first nation to respond, China's aggressive control measures appeared to have been effective in suppressing the first wave and keeping new cases under control. Here, we provide the historical context and details of China's public health response to COVID-19. We highlight the lessons and impact of the 2002-2003 SARS outbreak, which demonstrated the importance of transparency, surveillance and testing laboratories during an outbreak. We provide an overview of China's response strategy that was based on the principles of early detection, isolation, management and treatment and involved not only the large-scale coordination of multiple governmental bodies but also grass-root community participation throughout the country. These community-based organizations conducted active surveillance for febrile cases and provided support for those in quarantine and communities in lockdown. Importantly, these broader measures were supported by digital technology, including the extensive use of internet-based platforms and mobile applications (APPs). While there have been no significant increases in case numbers since April, there is still much concern over a second wave, considering the resumption of work and school, the lifting of travel restrictions and the outbreaks occurring globally. Control measures has since been implemented by provincial authorities, which includes continued surveillance and rapid testing. Although China's strict control measures may not suit every nation, the principles of early detection and isolation continue to hold true and have been a cornerstone of the initial and ongoing response to the COVID-19. 2020 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  COVID-19; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); coronavirus; pandemic; public health

Year:  2020        PMID: 32944357      PMCID: PMC7475588          DOI: 10.21037/jtd-20-2363

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   3.005


Introduction

The COVID-19 outbreak in mainland China

On December 31, 2019 the Wuhan Health Commission announced a cluster of 27 cases of atypical pneumonia. These cases were initially linked to the Huanan Seafood Market, which was closed and sanitized the following day (1). On January 8 the China Centers for Disease Control and Prevention (China CDC) officially announced the causative agent to be a novel coronavirus closely related to bat coronaviruses (2-4). Initial public health responses, concentrated in Wuhan, became a national emergency when cases were reported beyond Wuhan and human-to-human transmission was confirmed in a family cluster in Shenzhen, Guangdong province (5) ().
Figure 1

Timeline of major events in mainland China of the COVID-19 outbreak from December 2019 to March 2020. Blue, events in Wuhan; green, events in mainland China; yellow, research progress; red, announcements by the WHO.

Timeline of major events in mainland China of the COVID-19 outbreak from December 2019 to March 2020. Blue, events in Wuhan; green, events in mainland China; yellow, research progress; red, announcements by the WHO. On January 16, the China CDC upgraded the emergency response to level I, the highest level (). On January 20 the novel coronavirus was classified as a Category B pathogen, making it a legal requirement to immediately report cases. The lockdown of Wuhan was announced in the early morning of January 23, barring all citizens from leaving without special permission after 10 am. By this time cases had been reported in all provinces except Tibet. Complicating matter was chunyun, the Spring Festival travel season that is considered to be the largest human migration event globally (6). In 2020, the Spring Festival was slated to begin on January 25, and millions of residents had already left Wuhan prior to the lockdown (7).
Table 1

Structure of the public health emergency response levels of China

LevelAuthorization
IExtremely serious public health emergency
Coordinated at the State Council level
IISerious public health emergency
Coordinated at the provincial level with guidance from the State Council if required
IIIPublic health emergency
Coordinated at the municipal level with guidance from the Provincial Health Commission if required
IVGeneral public health emergency
Coordinated at the district level with guidance from the Municipal Health Commission if required
Between December 31, 2019 and March 22, 2020, considered the first COVID-19 wave, China recorded 80,695 confirmed cases (), 67,707 of which is in Hubei Province (). Wuhan alone recorded 49,912 cases (). The burden of the epidemic in China was borne primarily by Hubei Province, which accounted for 83% of its’ cases. Wuhan alone accounted for 62% of the national tally. Close to 700,000 close contacts were traced or monitored by the end of March (8). Between March 8 to June 12 2020, China has recorded only an additional 3,976 cases, 1,808 (45%) of these cases were diagnosed as imported cases (9).
Figure 2

Progression of the COVID-19 outbreak in mainland China. Epidemic trends of confirmed, suspected and new daily cases in China (A), Hubei Province (B) and Wuhan (C) between 11 January 2020 and 7 March 2020.

Progression of the COVID-19 outbreak in mainland China. Epidemic trends of confirmed, suspected and new daily cases in China (A), Hubei Province (B) and Wuhan (C) between 11 January 2020 and 7 March 2020. The goal of this review is to provide a cohesive overview of the response during the first wave of COVID-19 between December 2019 and April 2020 and to put this response into a historical context, namely the 2003 severe acute respiratory syndrome coronavirus (SARS-CoV) outbreak. Further, the greater national response has mostly been overshadowed by Wuhan’s lockdown, which was considered unprecedented in the early days. Our review attempts to provide a (I) broader perspective of the public health measures taken across mainland China, which was guided in a top-down approach and (II) highlighting the underappreciated but critical roles of grass-root communities and digital technology in this response. We present the following article in accordance with the Narrative Review reporting checklist (Available at http://dx.doi.org/10.21037/jtd-20-2363).

Methods

Search strategy and selection criteria

Data for this review published in English or Chinese were identified by searches of PubMed, Chinese State, Provincial, Municipal and local government authorities’ websites and the national or local news outlets published between December 1, 2019 to June 1, 2020. All articles in Chinese were first translated by software and manually reviewed by our bilingual team members.

The National Surveillance and Public Health System in China in the post-SARS era

In the last 30 years, China has dealt with several viral epidemics of zoonotic origin (). The human to human transmissibility of SARS-CoV that emerged in 2002 however, proved to be a significant test of China’s public health system and was catalytic for its reform (14,15). The early events of the SARS outbreak presented valuable learning opportunities for outbreak control (16,17). Interventions and control measures were put in place and mandatory quarantine for suspected or confirmed cases of SARS was introduced, as was epidemiologic tracing of close contacts, whom were also required to undergo home quarantine (18). Collective quarantine at designated facilities was also introduced (19). Guangdong province implemented a meticulous contact tracing system that included a questionnaire to be completed within 24 hours of reporting (20). Fever clinics were established, designated SARS hospitals were opened and public places were closed for several weeks (19). Guangdong, Hong Kong and Beijing were the hardest hit. At the end of 2003, 8,096 cases had been reported worldwide, 774 of which were fatal (13).
Table 2

Epidemics of significant public health concern in China in the last 30 years

PathogenOutbreak durationPeak activityEpicenterNumber of casesFatal cases
Avian influenza H5N1 (10,11)05/1997–current12/1997Hong Kong53 (2003–2020)31
Avian influenza H7N9 (12)2003–202004/2013Zhejiang1,568 (2013–2019)616
SARS (13)02/2013– 201902/2003Guangdong & Beijing5,327 (2002–2003)349
SARS-CoV-2 (8)2013–201902/2020Wuhan81,202a3,242

a, Number of cases in China as of 18 March, 2020.

a, Number of cases in China as of 18 March, 2020. Three key lessons were taken away from SARS: (I) the importance of transparency to ensure social stability, (II) the importance of disease surveillance, and, (III) the importance of testing laboratories. These elements formed the basis of the ‘Five Es’: “Early Detection”, “Early Notification”, “Early Diagnosis”, “Early Isolation” and “Early Treatment” (16). The government began to invest substantially in public health infrastructure by increasing funds, resources and the sizes of skilled workforces (14,15). To enable rapid reporting and monitoring, the Ministry of Health implemented the internet-based disease reporting system; the China Information System for Disease Control and Prevention (CISDCP). The CISDCP supports the real-time reporting of cases, a significant advantage over the previous reporting system requiring hospitals to submit case-report forms to local CDCs which then submitted monthly reports up the chain to the national CDC. The CISDCP is utilized in the national surveillance system established to detect emerging pathogens by the Chinese Ministry of Health under the “National Implementation Plan for Surveillance of Unexplained Pneumonia”, announced on August 4, 2004 (21) ().
Figure 3

Flowchart of steps in diagnosing a ‘pneumonia of unknown etiology’ (PUE). Published in the ‘National Implementation Plan for Surveillance of Unexplained Pneumonia’, announced August 4 2004 by the Chinese Ministry of Health (21).

Flowchart of steps in diagnosing a ‘pneumonia of unknown etiology’ (PUE). Published in the ‘National Implementation Plan for Surveillance of Unexplained Pneumonia’, announced August 4 2004 by the Chinese Ministry of Health (21).

China’s COVID-19 epidemic control and prevention program

The four elements considered critical to China’s response were: (I) the lockdown of Wuhan, (II) the implementation of interagency mechanisms to control the epidemic outside of Wuhan, (III) the reporting of daily cases and zero cases (no cases detected) by all cities and provinces of China, and (IV) the implementation of community level surveillance and support system. Recognizing the importance of interagency communication and coordination, the National Health Committee (NHC) led the formation of the State joint prevention and control mechanism on January 20. This mechanism involved a total of 32 ministries or departments forming various working groups that focused on different aspects including epidemic prevention and control, treatment, research, publicity, foreign affairs, and logistical support (22). To ensure transparency to the public, the NHC coordinated the collection and publication of the daily tally of new and zero cases across the nation beginning on January 21. Finally, fearing that mass migration will lead to uncontrolled spread, the high-level expert group recommended locking down Wuhan. January 23 marked the date on which control measures were implemented nationwide to contain the spread (23). A coordinated top-down prevention and control program was implemented by the NHC and China CDC through a nine-point plan (24) (). Provincial and county level heath authorities then released guidelines to be enacted by various entities such as companies, institutions and neighborhood committees.
Table 3

Summary of the nine-point plan introduced by the NHC and China CDC to combat the COVID-19 outbreak (24)

Nine “Key-Points” in the planDescription of contents within each “Key-Point”
1. Strengthening of organizational leadershipRoles and responsibilities of health authorities, CDCs and medical institutions
Provide work and technical plans
2. Case detection and reportingProcedures for case detection and reporting for medical institutions and local CDCs
3. Epidemiological investigationDefinition of the roles of CDCs in coordinating with medical institutions to collect reports of suspected and confirmed cases.
4. Specimen collection and testingSpecimen handling and testing protocols
Processes for testing at either local hospitals or designated laboratories
5. Case treatment and nosocomial infection prevention and controlRole of designated hospitals in treating and isolating suspected or confirmed cases and preventing nosocomial infection of health care workers
6. Tracking and management of close contactsRole of county-level health authorities in the tracking and management of close contacts at home or at centralized quarantine
7. Education and risk communicationRegular surveys of public awareness, education campaigns and prompt responses to public concerns
8. Training of medical and health professionalsProvide training to health professionals on epidemiological investigation, treatment, testing, reporting, management and biosafety
9. Strengthen laboratory testing capabilities and biosafety precautionsRole of CDCs and medical institutions in establishing diagnostic platforms
The severity of the outbreak led the NHC to adopt a different strategy in Wuhan and surrounding cities. The government mobilized resources to increase testing by fast-tracking approval for diagnostic kits, recruiting third-party diagnostic companies to build additional laboratory capacity, facilitating supply chains and making more isolation facilities available. In a well-publicized example, Wuhan built two new infectious disease hospitals in 10 days to manage severe cases. A number of ‘square cabin hospitals’ were also established in Wuhan to treat mild cases, which operated between February 5 and March 10, treating over 12,000 cases with a combined staff of more than 8,000 (25). Medical teams nationwide were mobilized to staff these new facilities and support the strained workforce in Wuhan (26). As of March 8, a total of 346 civilian medical teams consisting of 42,600 staff and more than 4,000 military medical personnel were deployed to Hubei Province (8,27) (Supplementary file). A critical aspect of early detection in Wuhan was active surveillance for febrile cases at the community level. On February 6, Wuhan implemented a city-wide temperature monitoring program to identify suspected cases. Using the community grid as the basic unit, working teams comprising of staff and volunteers were formed. A combination of on-site inspection and self-reporting was adopted. Citizens could perform temperature checks at home and self-report the results by phone or through the social media application (APP) WeChat. The working teams also saw to the needs and difficulties of the homebound residents (28). To minimize domestic spread, the national Spring Festival holiday was extended for three days, interprovincial road travel and tour activities were banned and border control and surveillance for febrile persons were enacted (29,30). Outside of Hubei Province, health authorities were directed to identify individuals coming from high-risks areas, track close contacts and rapidly isolate suspected cases (31). Inter-city measures to increase social distancing were implemented, including movement restrictions, the closure of public spaces, banning of mass gatherings and postponement of school start dates (). A total of 2,091 hospitals and 11,655 fever clinics were established across China for rapid detection and isolation of suspected cases (). To increase testing and detection capacities nationwide, local CDCs trained the laboratory staff of designated hospitals to perform diagnostic tests, reducing the reliance on a centralized testing (52,53).
Table 4

Summary of intervention policies enacted in mainland China in response to COVID-19

National policies (29,32-39)
   Extended the Official Spring Festival holiday to February 3
   Postponed school openings
   Banned all mass celebrations and activities
   Cancellation of tours organized by travel agencies
   Suspended inter-provincial buses between most the provinces
   Banned the illegal sale of wild animals
   Monitoring of body temperature in public places such as railway stations, airports, hospitals and supermarkets
   Established various online services to assist people in staying home, such as online classes, banking services and medical and psychological consultations
   Registration of people whom have traveled from Hubei Province to allow follow-up health monitoring, facilitating early discovery, early reporting and early quarantine
   Tracing the travel of all close contacts of confirmed patients and imposing a 14-day quarantine
   Mandatory use of facemasks in supermarkets and shopping malls
Additional provincial policies (40-50)
   Hubei Province
      Public transportation halted and population outflow from Wuhan and other cities in Hubei is limited
      Building or refitting projects to establish makeshift hospitals and quarantined areas
      Allowed clinical diagnosis as a method to diagnose cases
   Guangdong
      People visiting fever clinics must provide a naso-pharyngeal swab for nucleic acid testing
   Guangdong, Zhejiang & Beijing
      People must register their information when buying antipyretics and cough medicines
   Guangdong, Beijing & Liaoning
      Mandatory use of facemasks in public places
   Shenzhen, Hainan & Liaoning
      Buildings with confirmed cases are subject to mandatory quarantine
   Numerous provinces and cities
      Non-native residents must register for a Health Code upon arrival
Figure 4

Distribution of hospitals and fever clinics in mainland China. Number of (A) designated hospitals, and (B) fever clinics across all provinces in mainland China (51).

Distribution of hospitals and fever clinics in mainland China. Number of (A) designated hospitals, and (B) fever clinics across all provinces in mainland China (51). Although a uniformed response framework based on national guidelines was introduced, regional and local measures varied. For example, Guangzhou and Shenzhen, two first-tier cities in Southern China, implemented movement restrictions in residential areas (54). Shenzhen imposed a 14-day quarantine or rapid evacuation of entire residential buildings in which confirmed cases were identified (55). Several provinces also made the use of face masks mandatory in public places in the early days before this rule was eventually implemented nationwide. (56,57). Purchases of fever or cough medication over the counter in pharmacies in Beijing and Guangdong must be registered, whilst in other cities sale of these medications were suspended (58). People requiring these medications were instructed to visit a hospital as soon as possible (58). In some cities, restrictions were placed on the number of household members allowed to leave home. These measures effectively cancelled Spring Festival celebrations and greatly reduced migration and mobility ().
Figure 5

Effect of travel restrictions on chunyun migration patterns in mainland China. Migration indices for the 2019 (orange) and 2020 (green) on the 7th day of the Spring Festival, typically the peak of migration, in different provinces in mainland China. Values show the difference in migration index in each province between 2019 and 2020. Migration index based on the daily number of inbound and outbound events by rail, air and road traffic, were sourced from a web-based program: Baidu qianxi (in Chinese) (https://qianxi.baidu.com/).

Effect of travel restrictions on chunyun migration patterns in mainland China. Migration indices for the 2019 (orange) and 2020 (green) on the 7th day of the Spring Festival, typically the peak of migration, in different provinces in mainland China. Values show the difference in migration index in each province between 2019 and 2020. Migration index based on the daily number of inbound and outbound events by rail, air and road traffic, were sourced from a web-based program: Baidu qianxi (in Chinese) (https://qianxi.baidu.com/). Closed off management of residential and commercial areas was implemented nationwide, from villages to large cities, to enable surveillance and temperature monitoring (54). Citizen volunteers were recruited to man monitoring stations, conduct door-to-door health checks, monitor those in self-quarantine and enforce social distancing measures (59). Intensive public education and awareness efforts were established to promote hand-washing, health monitoring, social distancing and disinfection. Temperature scanning was enacted to identify and prohibit entry of suspected febrile individuals into public spaces (60). These measures were implemented by local anti-epidemic committees and replicated at multiple organizational levels nationwide. In summary, China’s epidemic control was coordinated from top-down but the participation at the grass-root community level ensured the critical citizen’s compliance and the implementation of its program.

The role of technology in the COVID-19 response

In the last decade, China has undergone rapid growth in the digital technology sector (61). In the work plan of January 27, the State Council urged local authorities to utilize big data and other technologies to facilitate disease tracking (62,63) (). As inter-city or inter-province travel by train or air requires a valid Chinese ID or passport, the movements of confirmed COVID-19 cases could be traced. Telecom operators also participated, submitting daily tele data reports to track population mobility dynamically, and internet giants such as Alibaba, Tencent and Baidu were encouraged to share the geographical locations of users (64). Some provinces and municipalities used this dataset to establish publicly-accessible web-based platforms providing de-identified details of confirmed cases, including disease course, exposure history and movements. As NHC requires the nationwide tally of daily new confirmed, suspected, recovered and fatal cases available to the public, internet search engines like Baidu made these data searchable down to the city level and linked them to other relevant data, including latest news updates and migration data (9).
Figure 6

Examples of online tools for public use during the outbreak. Screenshots showing websites that provided searchable locations of (A) confirmed cases, (B) designated hospitals and (C) fever clinics available in Guangzhou city; (D) screenshot of an online portal provided by the National Health Commission to track potential exposure to confirmed cases based on public transportation usage; (E) example of the colored coded QR codes to signify health status for passage permission. Green means healthy with no associated risks, yellow means applicant is either recorded as a close contact, did not disclose their health status or had not yet completed 14-day home isolation, while red indicates that the applicant was either a confirmed or suspected case or febrile.

Examples of online tools for public use during the outbreak. Screenshots showing websites that provided searchable locations of (A) confirmed cases, (B) designated hospitals and (C) fever clinics available in Guangzhou city; (D) screenshot of an online portal provided by the National Health Commission to track potential exposure to confirmed cases based on public transportation usage; (E) example of the colored coded QR codes to signify health status for passage permission. Green means healthy with no associated risks, yellow means applicant is either recorded as a close contact, did not disclose their health status or had not yet completed 14-day home isolation, while red indicates that the applicant was either a confirmed or suspected case or febrile. Other online services have also been established to help those under quarantine. Hospitals utilized online outpatient platforms to assist individuals using video-based consultations with doctors (32). QR code-based ‘Health Codes’ that can be displayed on mobile phones were also introduced. Health Codes are based on a 14-day history of daily self-reported health declarations, travel and exposure history and knowledge of local epidemic prevention information. They are required to gain access to public amenities, closed-off areas or to return to work. Based on the individual’s response, the generated codes are divided into green, yellow and red. Green means pass, while yellow and red mean isolation and treatment (). This model was initially introduced in Hangzhou City on February 11. By March 5, one billion Tencent Health Codes, which are the Health Codes with the most users, were issued to more than 800 million people (65), although its intercity or interprovince usage is still limited to cities or provinces that have established prior mutual agreements. Temperature monitoring has been an important component of the public health response. Large scale, automated infrared thermal scanning was implemented in airports, subway, and train stations while hand-held temperature sensors are used at other locations, such as buses, taxis restaurants and residential complexes (66). Some larger locations also employed facial recognition technology, allowing the identification of potentially febrile individuals. The rollout of the 5G network, which has come into service on a limited scale in hospitals and railway stations initially in Guangdong, Guangxi and Zhejiang Provinces, has facilitated these measures (67-69).

A problem of scale

The rapid spread of COVID-19 within Hubei Province rapidly overwhelmed diagnostic and healthcare capacities. Diagnostic kits based on real-time PCR methods were quickly deployed to Hubei Province by January 16, but the testing capacity was far from the capacity needed to diagnose the thousands of suspected daily cases (70). PCR testing delays created a bottleneck in case confirmation, which was necessary to access treatment. Therefore, the Hubei government revised case-confirmation criteria to include clinical diagnoses, leading to the addition of >14,000 cases overnight on February 13 (71). This measure allowed medical staff at the point-of-care to enact treatment and isolation measures more rapidly than previously possible. The A-like classification of SARS-CoV-2 as a Category A agent meant that all health care workers at risk of exposure must don level-3 PPE, consisting of a full-protection suit, respirator, eye-protection and multiple gloves. This, along with the mandatory use of face masks by the public, placed significant strain on manufacturing and supply chains. Severe shortages in hospital beds, particularly in Wuhan, was also a major problem. The strain on medical resources was likely a contributing factor to the case-fatality rates (CFRs) observed in Wuhan and Hubei, at 4.9% and 3.1%, respectively, compared to 0.16% elsewhere in China before February 4 (72).

The known unknowns

The 2-month long epidemic in China provided some critical information about this virus. A study of over 72,000 cases showed that the majority of infections (81%) were mild, with an unadjusted CFR of 2.3%, with the elderly and those with underlying conditions most at risk (3,73). This CFR should be considered in the context of active detection, isolation and treatment. For provinces aside from Hubei, where medical facilities were well-prepared for the epidemic, the CFR were less than 1%. The CFR reported across the different countries globally also reflected the importance of population demography and preparedness of medical resources. Although the median incubation time has been reported to be 4 days, latency periods of more than 20 days had also been observed (73). There are also some reports of relapse, whereby patients deemed negative tested positive again (74). Reports have suggested that this phenomenon could be in as many as 14% of discharged patients (75), although the transmission potential of such cases are unknown. Infectious viruses have also been recovered in stool and urine specimens and up to 50% of cases have detectable viral RNA in their excretions (76). Fecal shedding has also been detected in asymptomatic cases (77). Therefore, unlike SARS, where most cases developed symptomatic infections rapidly, SARS-CoV-2 could manifest a diverse range of outcomes. Long latency, asymptomatic or mildly symptomatic infections increases the difficulty of identifying cases.

A second wave?

With the reduction of local transmission, local governments are slowly allowing businesses and people to return. Restrictions in Hubei Province, but not Wuhan, were lifted on March 25, but citizens are still required to wear masks and have normal body temperatures in order to leave (78). Large cities like Shanghai and Guangzhou downgraded their public health response to level II on March 24 and February 24, respectively (79,80). The Wuhan lockdown was lifted on April 8, although residents must still apply for permission to leave (81). Schools, which has been closed since the Spring Festival, have mostly reopened by June 8th. A major challenge in China now is to prevent subsequent waves, which includes preventing imported cases from seeding local transmissions. Health declarations, PCR screening and mandatory quarantines for all incoming passengers, regardless of nationality, have been introduced at China’s major entry points (82). The Chinese Civil Aviation Authority has imposed stringent restrictions on air travel to and from China. Up to June 2020, these regulations restricted domestic airlines to one route to any country and one flight per week on these routes while foreign airlines were restricted to one route to China and no more than one flight per week on these routes. More recently however, they have introduced the “circuit breaker” policy, where airlines are penalized if substantial number of positive cases were detected on any one flight and rewarded if no positive cases were detected consecutively for 2 weeks (83). Further, foreign nationals holding visas or residence permits are temporarily suspended from entering China since 28 March 2020 (84). These travel restrictions have enabled early detection of imported cases and likely prevented the resurgence of local cases. Domestically, the resumption of work and school have been accompanied by aggressive testing, increased sanitations, hygiene and health monitoring and implementation of social distancing measures. Gatherings are still largely prohibited. Large institutions such as universities are encouraged to adopt practices that reduce crowding by staggering school periods and meal times. Measures such as temperature scans, sanitation stations, facemasks and health codes remain in place (85). The monitoring systems and responses are now largely coordinated by local health authorities at the provincial or county level, who will continue to conduct epidemiological investigations and activate cordon sanitaire when upon detection of positive cases.

Conclusions

What has distinguished COVID-19 from previous outbreaks has been the scale and speed by which this contagion had spread, facilitated by its infectivity and the global connectivity. There was rapid progress in pathogen identification and development of diagnostic tests aided by technological development, but this advantage was soon diminished when the outbreak escalated and testing capacities became limited (86). The economic consequences of a mass lockdown in China was substantial across many sectors, particularly in more traditional consumer-based industries. The service, investment, retail and export sectors fell by 13%, 24.5%, 20.5%, and 15.9%, respectively, compared to the same period last year. Unemployment rate increased by 0.9% between January to February 2020. Although substantial, the negative economic impact was likely buffered by the Spring Festival for some industries and the growth of others, such as the digital economy (87). We have attempted to provide a cohesive, but not necessarily exhaustive, review of China’s response to COVID-19. In order to streamline our review, we have primarily focused on China’s response to the first COVID-19 wave, which essentially set the foundation of their ongoing control efforts. China’s efforts appeared to have successfully controlled local transmissions of the first COVID-19 wave but it had taken massive coordination at every level of governmental and civilian authorities. China had the benefit of experience, gained during the 2003 SARS epidemic, and citizen compliance was a critical factor to the success of the control measures implemented. Internet-based platforms and mobile APPs were used extensively for the first time in an epidemic to facilitate large-scale, real-time risk communication. These newer technologies were applied concurrently with the ancient countermeasures of isolation and quarantine. Going forward, further understanding of the virus’s biology and transmission pattern will enable the implementation of a targeted, and less disruptive public health response. The principles of early detection and isolation continue to hold true and have been a cornerstone of the initial and ongoing response to the COVID-19 outbreak in China. The article’s supplementary files as
  16 in total

1.  SARS in China. China's missed chance.

Authors:  Martin Enserink
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

2.  The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report.

Authors:  Shi Zhao; Zian Zhuang; Jinjun Ran; Jiaer Lin; Guangpu Yang; Lin Yang; Daihai He
Journal:  Travel Med Infect Dis       Date:  2020-01-30       Impact factor: 6.211

3.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

4.  Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.

Authors:  Li-Li Ren; Ye-Ming Wang; Zhi-Qiang Wu; Zi-Chun Xiang; Li Guo; Teng Xu; Yong-Zhong Jiang; Yan Xiong; Yong-Jun Li; Xing-Wang Li; Hui Li; Guo-Hui Fan; Xiao-Ying Gu; Yan Xiao; Hong Gao; Jiu-Yang Xu; Fan Yang; Xin-Ming Wang; Chao Wu; Lan Chen; Yi-Wei Liu; Bo Liu; Jian Yang; Xiao-Rui Wang; Jie Dong; Li Li; Chao-Lin Huang; Jian-Ping Zhao; Yi Hu; Zhen-Shun Cheng; Lin-Lin Liu; Zhao-Hui Qian; Chuan Qin; Qi Jin; Bin Cao; Jian-Wei Wang
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

5.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

6.  Epidemiologic clues to SARS origin in China.

Authors:  Rui-Heng Xu; Jian-Feng He; Meiron R Evans; Guo-Wen Peng; Hume E Field; De-Wen Yu; Chin-Kei Lee; Hui-Min Luo; Wei-Sheng Lin; Peng Lin; Ling-Hui Li; Wen-Jia Liang; Jin-Yan Lin; Alan Schnur
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

7.  [Management of COVID-19: the Zhejiang experience].

Authors:  Kaijin Xu; Hongliu Cai; Yihong Shen; Qin Ni; Yu Chen; Shaohua Hu; Jianping Li; Huafen Wang; Liang Yu; He Huang; Yunqing Qiu; Guoqing Wei; Qiang Fang; Jianying Zhou; Jifang Sheng; Tingbo Liang; Lanjuan Li
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-02-21

8.  Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China.

Authors:  An Tang; Zhen-Dong Tong; Hong-Ling Wang; Ya-Xin Dai; Ke-Feng Li; Jie-Nan Liu; Wen-Jie Wu; Chen Yuan; Meng-Lu Yu; Peng Li; Jian-Bo Yan
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

Review 9.  Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.

Authors:  Fei Yu; Lanying Du; David M Ojcius; Chungen Pan; Shibo Jiang
Journal:  Microbes Infect       Date:  2020-02-01       Impact factor: 2.700

10.  A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period.

Authors:  Ping Yu; Jiang Zhu; Zhengdong Zhang; Yingjun Han
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

View more
  10 in total

1.  Waste management model for COVID-19: recommendations for future threats.

Authors:  D Yadav; S Mann; A Balyan
Journal:  Int J Environ Sci Technol (Tehran)       Date:  2022-07-12       Impact factor: 3.519

2.  Pregnant under quarantine: Women's agency and access to medical care under Wuhan's COVID-19 lockdown.

Authors:  Amy Hanser; Yue Qian
Journal:  SSM Qual Res Health       Date:  2022-05-17

3.  Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China.

Authors:  Mary Bushman; Colin Worby; Hsiao-Han Chang; Moritz U G Kraemer; William P Hanage
Journal:  Eur J Epidemiol       Date:  2021-04-21       Impact factor: 8.082

Review 4.  Application of artificial intelligence in COVID-19 medical area: a systematic review.

Authors:  Zhoulin Chang; Zhiqing Zhan; Zifan Zhao; Zhixuan You; Yang Liu; Zhihong Yan; Yong Fu; Wenhua Liang; Lei Zhao
Journal:  J Thorac Dis       Date:  2021-12       Impact factor: 3.005

5.  Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients.

Authors:  Manon Chauvin; Martin Larsen; Bibiana Quirant; Paul Quentric; Karim Dorgham; Luca Royer; Hélène Vallet; Amelie Guihot; Béhazine Combadière; Christophe Combadière; Jaume Barallat; Julien Mayaux; Charles-Edouard Luyt; Alexis Mathian; Zahir Amoura; Jacques Boddaert; Fernando Armestar; Guy Gorochov; Eva Martinez-Caceres; Delphine Sauce
Journal:  Front Cell Infect Microbiol       Date:  2021-08-23       Impact factor: 5.293

6.  Identification of the most vulnerable populations in the psychosocial sphere: a cross-sectional study conducted in Catalonia during the strict lockdown imposed against the COVID-19 pandemic.

Authors:  Judith Farrés; Jose Luis Ruiz; Jose Manuel Mas; Lilibeth Arias; Maria-Rosa Sarrias; Carolina Armengol; Pere-Joan Cardona; Jose A Munoz-Moreno; Miriam Vilaplana; Belen Arranz; Judith Usall; Antoni Serrano-Blanco; Cristina Vilaplana
Journal:  BMJ Open       Date:  2021-11-26       Impact factor: 2.692

7.  Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era.

Authors:  Guangyu Lu; Yuanyuan Cao; Dongying Zhang; Yuying Zhang; Yuhui Xu; Yan Lu; Qi Chen; Guoding Zhu; Jun Yan; Olaf Müller; Jun Cao
Journal:  Global Health       Date:  2022-06-21       Impact factor: 10.401

8.  Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy.

Authors:  Carmela De Marco; Claudia Veneziano; Alice Massacci; Matteo Pallocca; Nadia Marascio; Angela Quirino; Giorgio Settimo Barreca; Aida Giancotti; Luigia Gallo; Angelo Giuseppe Lamberti; Barbara Quaresima; Gianluca Santamaria; Flavia Biamonte; Stefania Scicchitano; Enrico Maria Trecarichi; Alessandro Russo; Daniele Torella; Aldo Quattrone; Carlo Torti; Giovanni Matera; Caterina De Filippo; Francesco Saverio Costanzo; Giuseppe Viglietto
Journal:  Front Microbiol       Date:  2022-07-28       Impact factor: 6.064

Review 9.  COVID-19 in Germany and China: mitigation versus elimination strategy.

Authors:  Guangyu Lu; Oliver Razum; Albrecht Jahn; Yuying Zhang; Brett Sutton; Devi Sridhar; Koya Ariyoshi; Lorenz von Seidlein; Olaf Müller
Journal:  Glob Health Action       Date:  2021-01-01       Impact factor: 2.640

10.  The impact of the COVID-19 pandemic on health services utilization in China: Time-series analyses for 2016-2020.

Authors:  Hong Xiao; Xiaochen Dai; Bradley H Wagenaar; Fang Liu; Orvalho Augusto; Yan Guo; Joseph M Unger
Journal:  Lancet Reg Health West Pac       Date:  2021-03-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.